Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ophelia
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ophelia

Ophelia

Series B

Ophelia: Telemedicine-based opioid addiction treatment with medication and support.

HQ
New York City, NY, US
Founded
2019
Accelerator
Y Combinator logoY CombinatorW20
Overview
Compare
Fundraising
Employees
News
Website

Ophelia was founded with the mission to provide accessible, effective, and private treatment for opioid addiction through telemedicine. The company offers online doctor’s visits, withdrawal medication prescriptions, and long-term recovery support, aiming to address the needs of over 3 million Americans struggling with opioid addiction. Ophelia's protocol is touted to be six times more effective than traditional rehab programs, many of which lack medical oversight. The service is designed to be discreet and convenient, making it suitable for individuals with jobs, families, and privacy concerns.

Notable figures affiliated with Ophelia include experts in addiction medicine and telehealth. The company has garnered attention for its innovative approach and has likely attracted investment from venture capital firms interested in health tech solutions. Key achievements include the successful treatment of numerous patients who might otherwise have avoided seeking help due to stigma or logistical barriers. Overall, Ophelia has made a significant impact by offering a viable alternative to traditional rehab, increasing access to life-saving treatments, and contributing to the broader fight against the opioid crisis.

Ophelia - Similar Companies

Bicycle Health logo

Bicycle Health

bicyclehealth.com

Pelago logo

Pelago

pelagohealth.com

Boulder Care logo

Boulder Care

boulder.care

Sonara Health logo

Sonara Health

sonarahealth.com

PursueCare logo

PursueCare

pursuecare.com

Alpha Medical logo

Alpha Medical

helloalpha.com

Folx Health logo

Folx Health

folxhealth.com

Dr.Online logo

Dr.Online

dronline.com

Ella logo

Ella

Cerebral logo

Cerebral

cerebral.com

Backpack Healthcare logo

Backpack Healthcare

HealthLinkNow logo

HealthLinkNow

healthlinknow.com

Ro logo

Ro

ro.co

Options MD logo

Options MD

optionsmd.com

Float Health logo

Float Health

float.health

Ophelia - Quick Facts

Who are Ophelia's competitors?

Companies similar to Ophelia include Bicycle Health, Pelago, Boulder Care and Sonara Health.

When was Ophelia founded?

Ophelia was founded in 2019.

Where is Ophelia's headquarters located?

Ophelia's headquarters is located in New York City, NY, US.

When was Ophelia's last funding round?

Ophelia's most recent funding round was for $50M (USD) in December 2021.

How much has Ophelia raised to-date?

As of Dec 14, 2021, Ophelia has raised a total of $67.7M (USD).

How many employees does Ophelia have?

Ophelia has 130 employees as of Feb 20, 2024.

Ophelia - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Medication
  • Telemedicine
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified